Achillion Pharmaceuticals, Inc. Reports First Quarter 2014 Financial Results
Published: May 07, 2014
NEW HAVEN, Conn., May 7, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported financial results for the three months ended March 31, 2014. For the first quarter of 2014, the Company reported a net loss of $16.1 million or $0.17 per share, compared with a net loss of $11.7 million or $0.14 per share for the first quarter of 2013. Cash, cash equivalents, marketable securities and interest receivable as of March 31, 2014 were $144.7 million.
Help employers find you! Check out all the jobs and post your resume.